Stay updated on UC-961 in Relapsed CLL Clinical Trial
Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.

Latest updates to the UC-961 in Relapsed CLL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new 'Locations' section with a California entry to the study details and updated the revision to v3.3.3. Removed the previous California Locations block and the HHS Vulnerability Disclosure footer, with the change history adjusted from v3.3.2.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPublication note wording was changed from 'the study results' to 'the results of the study', and the revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding/operating status notice that previously informed users about NIH operations and update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe two screenshots display the same Study Details page for NCT02222688, with no observable changes in content or layout.SummaryDifference0.4%

- Check92 days agoChange DetectedUpdate to version v3.2.0 with a government operating status notice; removal of the B-cell chronic lymphocytic leukemia resource (v3.1.0).SummaryDifference3%

- Check99 days agoChange DetectedUpdate: version revision changed from v3.0.2 to v3.1.0 to reflect a newer release.SummaryDifference0.1%

Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.